BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 35149189)

  • 1. Elucidating inhaled liposome surface charge on its interaction with biological barriers in the lung.
    Zhao J; Qin L; Song R; Su J; Yuan Y; Zhang X; Mao S
    Eur J Pharm Biopharm; 2022 Mar; 172():101-111. PubMed ID: 35149189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring the influence of inhaled liposome membrane fluidity on its interaction with pulmonary physiological barriers.
    Zhao J; Su J; Qin L; Zhang X; Mao S
    Biomater Sci; 2020 Dec; 8(23):6786-6797. PubMed ID: 33146657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of a biomimetic pulmonary surfactant modification on the in vivo fate of nanoparticles in the lung.
    Liu Q; Xue J; Zhang X; Chai J; Qin L; Guan J; Zhang X; Mao S
    Acta Biomater; 2022 Jul; 147():391-402. PubMed ID: 35643196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design of liposomes to improve delivery of macrophage-augmenting agents to alveolar macrophages.
    Fidler IJ; Raz A; Fogler WE; Kirsh R; Bugelski P; Poste G
    Cancer Res; 1980 Dec; 40(12):4460-6. PubMed ID: 7002293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liposome-cell interactions in vitro: effect of liposome surface charge on the binding and endocytosis of conventional and sterically stabilized liposomes.
    Miller CR; Bondurant B; McLean SD; McGovern KA; O'Brien DF
    Biochemistry; 1998 Sep; 37(37):12875-83. PubMed ID: 9737866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design of liposomal aerosols for improved delivery of rifampicin to alveolar macrophages.
    Vyas SP; Kannan ME; Jain S; Mishra V; Singh P
    Int J Pharm; 2004 Jan; 269(1):37-49. PubMed ID: 14698575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary effects of chronic exposure to liposome aerosols in mice.
    Myers MA; Thomas DA; Straub L; Soucy DW; Niven RW; Kaltenbach M; Hood CI; Schreier H; Gonzalez-Rothi RJ
    Exp Lung Res; 1993; 19(1):1-19. PubMed ID: 8440200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of the charge distribution on liposome particles aerosolized by air-jet atomization.
    Chadha TS; Chattopadhyay S; Venkataraman C; Biswas P
    J Aerosol Med Pulm Drug Deliv; 2012 Dec; 25(6):355-64. PubMed ID: 22551083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nose-to-brain/spinal cord delivery kinetics of liposomes with different surface properties.
    Kurano T; Kanazawa T; Ooba A; Masuyama Y; Maruhana N; Yamada M; Iioka S; Ibaraki H; Kosuge Y; Kondo H; Suzuki T
    J Control Release; 2022 Apr; 344():225-234. PubMed ID: 35296406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liposomal Aerosols of Nitric Oxide (NO) Donor as a Long-Acting Substitute for the Ultra-Short-Acting Inhaled NO in the Treatment of PAH.
    Nahar K; Rashid J; Absar S; Al-Saikhan FI; Ahsan F
    Pharm Res; 2016 Jul; 33(7):1696-710. PubMed ID: 27048347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of calcitonin-containing liposome formulations for intranasal delivery.
    Law SL; Shih CL
    J Microencapsul; 2001; 18(2):211-21. PubMed ID: 11253938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interplay between mucus mobility and alveolar macrophage targeting of surface-modified liposomes.
    Japiassu KB; Fay F; Marengo A; Louaguenouni Y; Cailleau C; Denis S; Chapron D; Tsapis N; Nascimento TL; Lima EM; Fattal E
    J Control Release; 2022 Dec; 352():15-24. PubMed ID: 36209941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring the influence of microstructure and phospholipid type of liposomes on their interaction with lung.
    Zhao J; Yuan Y; Xue J; Hou A; Song S; Guan J; Zhang X; Mao S
    Eur J Pharm Biopharm; 2024 May; 198():114271. PubMed ID: 38537907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peritoneal retention of liposomes: Effects of lipid composition, PEG coating and liposome charge.
    Dadashzadeh S; Mirahmadi N; Babaei MH; Vali AM
    J Control Release; 2010 Dec; 148(2):177-86. PubMed ID: 20800629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uptake of charged liposomes by the rat liver.
    Yu HY; Lin CY
    J Formos Med Assoc; 1997 Jun; 96(6):409-13. PubMed ID: 9216162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of murine liver macrophage clearance of liposomes by diethylstilbestrol. The effect of vesicle surface charge and a role for the complement receptor Mac-1 (CD11b/CD18) of newly recruited macrophages in liposome recognition.
    Moghimi SM; Patel HM
    J Control Release; 2002 Jan; 78(1-3):55-65. PubMed ID: 11772449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of a liposome system for the delivery of desferrioxamine to lungs in rats.
    Tabak A; Hoffer E; Taitelman U
    J Pharm Pharmacol; 1994 Oct; 46(10):789-96. PubMed ID: 7699564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphatic delivery and pharmacokinetics of methotrexate after intramuscular injection of differently charged liposome-entrapped methotrexate to rats.
    Kim CK; Han JH
    J Microencapsul; 1995; 12(4):437-46. PubMed ID: 8583318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nano- and micro-based inhaled drug delivery systems for targeting alveolar macrophages.
    Lee WH; Loo CY; Traini D; Young PM
    Expert Opin Drug Deliv; 2015 Jun; 12(6):1009-26. PubMed ID: 25912721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The surface charge of liposomal adjuvants is decisive for their interactions with the Calu-3 and A549 airway epithelial cell culture models.
    Ingvarsson PT; Rasmussen IS; Viaene M; Irlik PJ; Nielsen HM; Foged C
    Eur J Pharm Biopharm; 2014 Aug; 87(3):480-8. PubMed ID: 24726978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.